Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Pullen

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Plos One|May 13, 2016
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseM Nusrat Sharif, Gabriela Campanholle, Eva E Nagiec, et al.
Viruses|January 22, 2022
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional StudyAnia Wisniak, Lakshmi Krishna Menon, Roxane Dumont, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
Nature Communications|June 9, 2021
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandSilvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Lancet. Infectious Diseases|February 4, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peakSilvia Stringhini, María-Eugenia Zaballa, Javier Perez-Saez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 29, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
Journal of Medicinal Chemistry|December 30, 2021
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1Agustin Casimiro-Garcia, Christophe Allais, Agnes Brennan, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Plos One|May 13, 2016
Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney DiseaseM Nusrat Sharif, Gabriela Campanholle, Eva E Nagiec, et al.
Viruses|January 22, 2022
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional StudyAnia Wisniak, Lakshmi Krishna Menon, Roxane Dumont, et al.
Regulatory Toxicology and Pharmacology : RTP|November 22, 2011
The design of chronic toxicology studies of monoclonal antibodies: implications for the reduction in use of non-human primatesKathryn L Chapman, Laura Andrews, Jeffrey J Bajramovic, et al.
Nature Communications|June 9, 2021
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, SwitzerlandSilvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Lancet. Infectious Diseases|February 4, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peakSilvia Stringhini, María-Eugenia Zaballa, Javier Perez-Saez, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 29, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021Silvia Stringhini, María-Eugenia Zaballa, Nick Pullen, et al.
The Lancet Regional Health. Europe|December 7, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based studyMaría-Eugenia Zaballa, Javier Perez-Saez, Carlos de Mestral, et al.
Journal of Medicinal Chemistry|December 30, 2021
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1Agustin Casimiro-Garcia, Christophe Allais, Agnes Brennan, et al.
Pageof 6